Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression

Status

UNKNOWN

Phases

Phase 4

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02443844

Enrollment

Registered

2015-05-14

Start date

2015-02-28

Completion date

2020-02-29

Last updated

2015-05-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Keywords

BPH, bladder cancer, treatment, recurrence, progression

Brief summary

The purpose of this study is to compare medical and surgical treatments of benign prostate hyperplasia in patients who have non muscle invasive bladder cancer for tumour recurrence and progression.

Interventions

PROCEDURETransurethral Resection

Endoscopic treatment of bladder cancer

DRUGTamsulosin

Medical treatment for benign prostate hyperplasia

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

MALE

Age

40 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patients who have non muscle invasive bladder cancer male patients patients between 40-80 years old

Exclusion criteria

* Patients who have previous prostate surgery Patients who have muscle invasive bladder cancer

Design outcomes

Primary

Measure	Time frame	Description
Recurrence	3 years	Bladder cancer recurrence rate

Secondary

Measure	Time frame	Description
Progression	3 years	Bladder cancer progression rate

Countries

Turkey (Türkiye)

Contacts

Primary ContactNihat Karakoyunlu, MD

nkarakoyunlu@gmail.com00905324747134

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026